Clincosm LogoSign in Get a demo

Myeloproliferative Disorders

Showing 1 - 25 of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)

Not yet recruiting
  • Myeloproliferative Disorders
  • +3 more
  • (no location specified)
Nov 21, 2023

Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Cytokine Induced Memory-like Natural Killer Cells
  • Interleukin-2
  • Boston, Massachusetts
  • +1 more
Nov 14, 2023

Immune System Diseases, Autoimmune Diseases, Inflammation Trial (observational cohort study)

Not yet recruiting
  • Immune System Diseases
  • +15 more
  • observational cohort study
  • (no location specified)
Jul 23, 2023

Myeloproliferative Disorders, Leukemia Trial in Boston (Cardiac Lifestyle Program)

Not yet recruiting
  • Myeloproliferative Disorders
  • Leukemia
  • Cardiac Lifestyle Program
  • Boston, Massachusetts
  • +2 more
May 1, 2023

Epidemiological and Clinical-pathological Factors of

Completed
  • Myeloproliferative Neoplasm
  • +4 more
    • Guayaquil, Guayas, Ecuador
      Sociedad de Lucha Contra el Cáncer
    Apr 25, 2023

    Leukemia, Acute, MDS, Myelomonocytic Leukemia, Chronic Trial (Itacitinib)

    Not yet recruiting
    • Leukemia, Acute
    • +7 more
    • (no location specified)
    Apr 10, 2023

    Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete

    Completed
    Has Results
    • Myeloproliferative Disorders
    • +4 more
    • T-cell replete PBPC allograft
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Oct 12, 2022

    Pathogenesis of Hematologic Malignancies

    Enrolling by invitation
    • Acute Leukemia
    • +3 more
    • blood draw, bone marrow procedure, or tissue biopsy
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Sep 9, 2022

    Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)

    Recruiting
    • Myeloproliferative Disorders
    • +4 more
    • La Jolla, California
    • +184 more
    Aug 22, 2022

    Thrombocytopenia, Hematologic Malignancy, Bone Marrow Aplasia Trial in Israel, Norway, United States (Thrombosomes, Liquid

    Suspended
    • Thrombocytopenia
    • +5 more
    • Thrombosomes
    • Liquid Stored Platelets (LSP)
    • Duarte, California
    • +5 more
    Apr 21, 2022

    Intravenous Busulfan And Fludarabine Myeloablative Conditioning

    Completed
    • Acute Myeloid Leukemia
    • +3 more
      • (no location specified)
      Mar 16, 2022

      Myeloproliferative Disorders, Lymphoproliferative Disorders Trial in Pierre-Bénite (Blood collection for the evaluation of the

      Not yet recruiting
      • Myeloproliferative Disorders
      • Lymphoproliferative Disorders
      • Blood collection for the evaluation of the anti-drugs sensitivity
      • Pierre-Bénite, France
      • +1 more
      Mar 2, 2022

      Myeloid Malignancies, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial in Hackensack (Fludarabine and Busulfan

      Active, not recruiting
      • Myeloid Malignancies
      • +4 more
      • Fludarabine and Busulfan plus/minus Total Body Irradiation (low dose)
      • Fludarabine and Busulfan + Low Dose Total Body Irradiation (LD TBI)
      • Hackensack, New Jersey
        John Theurer Cancer Center at Hackensack University Medical Cent
      Feb 25, 2022

      Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia Trial in Stanford

      Recruiting
      • Allogeneic Hematopoietic Cell Transplantation (HCT)
      • +5 more
      • Purified regulatory T-cells (Treg) plus CD34+ HSPC
      • +7 more
      • Stanford, California
        Stanford University
      Oct 28, 2021

      Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in Leiden (MDG1021 dose 1, MDG1021 dose 2, MDG1021 dose 3)

      Withdrawn
      • Acute Myeloid Leukemia
      • +7 more
      • MDG1021 dose 1
      • +3 more
      • Leiden, Zuid Holland, Netherlands
        Leiden University Medical Centre
      Sep 30, 2021

      Myeloproliferative Neoplasm and Splanchnic Vein Thrombosis

      Active, not recruiting
      • Myeloproliferative Neoplasm
      • +3 more
      • standard of care.
      • (no location specified)
      Sep 14, 2021

      Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, Leukemia, Myelocytic, Chronic Trial in Belgium (Mesenchymal stem

      Terminated
      • Leukemia, Myeloid, Acute
      • +8 more
      • Mesenchymal stem cells
      • Isotonic solution
      • Edeghem, Antwerpen, Belgium
      • +9 more
      Aug 31, 2021

      Cancer, Metastatic, Cancer, Cancer of Pancreas Trial in New York (Clinical Trial Matching)

      Recruiting
      • Cancer, Metastatic
      • +42 more
      • Clinical Trial Matching
      • New York, New York
        Massive Bio, Inc
      May 21, 2021

      Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Minneapolis (biological, drug, procedure, radiation)

      Completed
      Has Results
      • Myeloproliferative Disorders
      • +3 more
      • anti-thymocyte globulin
      • +6 more
      • Minneapolis, Minnesota
        Masonic Cancer Center at University of Minnesota
      Oct 30, 2020

      Pulmonary Hypertension in Myeloproliferative Neoplasms

      Completed
      • Myeloproliferative Disorders
      • Pulmonary Hypertension
      • Radiology
      • Odense, Denmark
        Odense University Hospital
      Sep 15, 2020

      Primary Myelofibrosis, Thrombocytosis, Essential Thrombocythemia Trial in Worldwide (LDE225, INC424)

      Completed
      Has Results
      • Primary Myelofibrosis
      • +9 more
      • Camperdown, New South Wales, Australia
      • +17 more
      Apr 3, 2020

      Dysregulated Signaling in MPD Via Multiparameter

      Terminated
      • Myeloproliferative Disorders
      • Myeloproliferative Disorders (MPD)
        • Stanford, California
          Stanford University School of Medicine
        Apr 7, 2020

        Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Myeloproliferative Disorders Trial in Perugia (High dose irradiation

        Recruiting
        • Acute Myeloid Leukemia
        • +5 more
        • High dose irradiation conditioning + Treg/Tcon
        • Perugia, PG, Italy
          University of Perugia
        Jan 8, 2020

        Neural Tube Defects, Anemia, Leukemia, Myeloid Trial in Stanford (CIK cells, Cyclosporine, Mycophenolate Mofetil)

        Completed
        Has Results
        • Neural Tube Defects
        • +5 more
        • CIK cells
        • +4 more
        • Stanford, California
          Stanford University School of Medicine
        Apr 18, 2019

        Primary Myelofibrosis, Myeloproliferative Disorders Trial in Saint-Petersburg (Allogeneic hematopoietic stem cell

        Completed
        • Primary Myelofibrosis
        • Myeloproliferative Disorders
        • Allogeneic hematopoietic stem cell transplantation
        • +4 more
        • Saint-Petersburg, Russian Federation
          First Pavlov State Medical University of St. Petersburg
        Apr 3, 2019